Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022055

Sr. VP, New Prod. Strat. & Dev sold 2,125 shares at $9.63 ($20,464)

From the SEC's structured data for this filing

Trades in this filing

Kieffer Tara Lynn · Sr. VP, New Prod. Strat. & Dev

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-05 Sale : show line 1 in the form −2,125 $9.63 $20,464 37,260 D
Open-market sales · 2,125 sh · avg $9.63 · $20,464
Loading xslF345X05/form4.xml…